Sharon Macrohon-Sabaitue
Adult Health · Hollywood, FLNPI 1497036602
Payments from drug & device makers
Across 170 payments — averaging $22.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$663
- Lilly USA, LLC$510
- Amgen$358
- Novo Nordisk$355
- Dexcom, Inc.$263
- Novartis$245
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,891100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 23 | $663 |
| Lilly USA, LLC | 22 | $510 |
| Amgen | 25 | $358 |
| Novo Nordisk | 15 | $355 |
| Dexcom, Inc. | 5 | $263 |
| Novartis | 6 | $245 |
| Exact Sciences | 9 | $196 |
| Abbott | 6 | $185 |
| Hologic Sales And Service, LLC | 11 | $172 |
| Boehringer Ingelheim | 6 | $150 |
| AbbVie | 7 | $149 |
| Intra-sana Laboratories | 11 | $141 |
| Pfizer | 5 | $108 |
| Kowa Pharmaceuticals America, Inc. | 6 | $101 |
| GSK | 3 | $69 |
| Johnson & Johnson | 3 | $59 |
| Phadia US Inc. | 2 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $35 |
| Gilead | 1 | $35 |
| Indivior Inc. | 1 | $26 |
| Hikma Pharmaceuticals USA | 1 | $19 |
| Medtronic | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G6 TRANSMITTER$156
- AIRSUPRA$125
- FreeStyle Libre$117
- LEQVIO$114
How this compares
$3,891 in reported general payments places this provider in the 85th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 36 | $38,586 |
| OzempicSemaglutide | 35 | $32,600 |
| FarxigaDapagliflozin Propanediol | 26 | $30,932 |
| EliquisApixaban | 32 | $22,425 |
| TradjentaLinagliptin | 12 | $14,787 |
| JardianceEmpagliflozin | 14 | $10,332 |
| Repatha SureclickEvolocumab | 16 | $8,573 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $2,106 |
| Rosuvastatin Calcium | 104 | $1,211 |
| Losartan Potassium | 115 | $1,171 |
| Gabapentin | 64 | $922 |
| Atorvastatin Calcium | 88 | $889 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 41 | $802 |
| Levothyroxine Sodium | 50 | $637 |
| Pantoprazole Sodium | 69 | $627 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $510 | $38,58636 claims |
| Novo NordiskOzempic | $355 | $32,60035 claims |
| AstraZenecaFarxiga | $663 | $30,93226 claims |
| Boehringer IngelheimTradjenta, Jardiance | $150 | $25,11926 claims |
| PfizerEliquis | $108 | $22,42532 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,237 adult health providers in Florida.
Other adult health in Hollywood
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Alejandro Dela CruzOrlando$44K
- Cynthia OteroMaitland$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.